Radence expands concierge membership to detect and prevent disease before it occurs

By pioneering a category defined as "concierge science," Radence disrupts traditional healthcare and sets the new benchmark for health span optimization.

PALM BEACH, Fla., Oct. 14, 2025 /PRNewswire/ -- Radence has introduced a concierge membership service designed to help individuals optimize their health span. By combining advanced technologies with personalized precision medicine, Radence establishes the most in-depth clinical baseline and detects subtle patterns and risks long before symptoms emerge, empowering individuals and their clinicians to act early to prevent and intercept chronic disease.

Radence takes a rigorously evidence-based multimodal approach that combines genomics, advanced blood panels, imaging, wearables, microbiome analysis and other breakthrough technologies to create a detailed personalized health and risk profile for each member. Leading experts assess and analyze the data and partner with the member's existing clinical care team to create and implement a custom health plan tailored to the individual's unique needs.

The plan, which is continuously updated based on ongoing monitoring and new research results, focuses on four actionable pillars of personalized prevention: cardiovascular and neurovascular health, cancer risk and detection, neurological and cognitive health, and metabolic and hormonal health and inflammation management.

"In essence, Radence is giving members the power to shape their story before it's written," said David Medvedeff, Radence CEO. "The ability to intervene early to actively guide the trajectory of their future health gives people a great sense of control and peace of mind. In fact, our company was founded because this service was something we wanted for ourselves and our families, and we recognized that recent scientific developments have created the opportunity to access the future of health care today."

Radence is backed by RA Ventures, the health care incubator of RA Capital Management, and a team of more than 50 MDs and PhDs dedicated to funding the development of novel medicines and tests. Radence draws on the research and predictive power of RA Capital's TechAtlas division, which serves as a world-class think tank, continuously analyzing scientific and clinical data from around the world.

While members have full access to Radence's extensive network of top specialists when needed, the company's model is based on collaboration with members' existing primary care physicians and other clinical partners. This approach allows members to maintain trusted relationships and clinicians to preserve the integrity of their practice. Radence's precision-guided preventive care model enhances patient outcomes without adding unnecessary complexity to providers' workflow or requiring them to invest in cutting-edge diagnostics and data-driven tools themselves.

"There is a great deal of noise in this space," said Dr. Julie Chen, Radence chief medical officer. "Science, technology and medicine are progressing rapidly, and most primary care clinicians, including concierge physicians, don't have the time or specialized expertise to sort through massive amounts of new research to identify what is hype, what is real but premature and what they should actually be implementing right now. Our team of MDs and PhDs, plus access to top specialists and key opinion leaders, allows us to vet the data and bridge the gap between emerging science and clinical practice. Ultimately, the goal is to compress the timeline between the introduction of cutting-edge technology and clinical usability in order to make transformational diagnostics and treatments more widely available sooner."

Limited memberships are available nationwide. Radence partners with preeminent diagnostic laboratories and medical imaging facilities across the country and deploys proprietary protocols and multiple levels of evaluation to deliver unsurpassed quality in testing and assessment.

For more information or to explore membership, please visit Radence.com.

About Radence
Radence was founded to detect and prevent disease before it occurs. Through a concierge model, the company provides members and their clinical care teams with leading-edge access to the world's most advanced prevention, early detection and treatment strategies, integrated into an entirely new and comprehensive approach to personalized precision medicine. Drawing on proprietary testing and screening protocols that are grounded in rigorous science and fueled by cutting-edge technology and unmatched data-driven insights, Radence uncovers early signals of future disease, helping members spend more of their years in peak health.

Radence Media Contact: Hannah Castle, 510-590-0195 [email protected]

SOURCE Radence